Ionis Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Ionis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker IONS.
Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy...
Can you invest in Ionis Pharmaceuticals, Inc.?
Yes. Ionis Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker IONS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ionis Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.